Diagnostic value of cancer-testis antigen mRNA in peripheral blood from hepatocellular carcinoma patients

World Journal of Gastroenterology

Volumn 16, Issue 32, 2010, Pages 4072-4078

  Zhao, Li ^a   Mou, Dong Cheng ^a   Peng, Ji Run ^b   Huang, Lei ^b   Wu, Zeng An ^a   Leng, Xi Sheng ^b  

^a WANGJING HOSPITAL   (China)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Cancer testis antigen; Diagnosis; Hepatocellular carcinoma; Nested reverse transcripts polymerase chain reaction; fetoprotein

Indexed keywords

ALPHA FETOPROTEIN; CANCER TESTIS ANTIGEN; MELANOMA ANTIGEN 1; MESSENGER RNA; PROTEIN SSX 1; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLOOD SAMPLING; CANCER STAGING; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 77956625908     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i32.4072     Document Type: Article

References (45)

1. Jain S, Singhal S, Lee P, Xu R. Molecular genetics of hepatocellular neoplasia. Am J Transl Res 2010; 2: 105-118
2. Paul SB, Manjunatha YC, Acharya SK. Palliative treatment in advanced hepatocellular carcinoma: has it made any difference? Trop Gastroenterol 2009; 30: 125-134
3. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108
4. Padma S, Martinie JB, Iannitti DA. Liver tumor ablation: percutaneous and open approaches. J Surg Oncol 2009; 100: 619-634
5. Stefaniuk P, Cianciara J, Wiercinska-Drapalo A. Present and future possibilities for early diagnosis of hepatocellular carcinoma. World J Gastroenterol 2010; 16: 418-424
6. Bialecki ES, Di Bisceglie AM. Diagnosis of hepatocellular carcinoma. HPB (Oxford) 2005; 7: 26-34
7. Gupta S, Bent S, Kohlwes J. Test characteristics of alphafetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis. Ann Intern Med 2003; 139: 46-50
8. Colombo M. Screening for cancer in viral hepatitis. Clin Liver Dis 2001; 5: 109-122
9. Johnson PJ. The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma. Clin Liver Dis 2001; 5: 145-159
10. Befeler AS, Di Bisceglie AM. Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 2002; 122: 1609-1619
11. Smith B, Selby P, Southgate J, Pittman K, Bradley C, Blair GE. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991; 338: 1227-1229
12. Raj GV, Moreno JG, Gomella LG. Utilization of polymerase chain reaction technology in the detection of solid tumors. Cancer 1998; 82: 1419-1442
13. Merrie AE, Yun K, McCall JL. Utilization of polymerase chain reaction technology in the detection of solid tumors. Cancer 1999; 85: 248-250
14. Clarke LE, Leitzel K, Smith J, Ali SM, Lipton A. Epidermal growth factor receptor mRNA in peripheral blood of patients with pancreatic, lung, and colon carcinomas detected by RTPCR. Int J Oncol 2003; 22: 425-430
15. Mou DC, Cai SL, Peng JR, Wang Y, Chen HS, Pang XW, Leng XS, Chen WF. Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells. Br J Cancer 2002; 86: 110-116
16. Chen CH, Chen GJ, Lee HS, Huang GT, Yang PM, Tsai LJ, Chen DS, Sheu JC. Expressions of cancer-testis antigens in human hepatocellular carcinomas. Cancer Lett 2001; 164: 189-195
17. Zendman AJ, Cornelissen IM, Weidle UH, Ruiter DJ, van Muijen GN. CTp11, a novel member of the family of human cancer/testis antigens. Cancer Res 1999; 59: 6223-6229
18. Chen H, Cai S, Wang Y, Zhao H, Peng J, Pang X, Zhu J, Cong X, Rui J, Leng X, Du R, Wang Y, Vaughan H, Cebon J, Burgess AW, Chen W. Expression of the MAGE-1 gene in human hepatocellular carcinomas. Chin Med J (Engl) 2000; 113: 1112-1118
19. Tahara K, Mori M, Sadanaga N, Sakamoto Y, Kitano S, Makuuchi M. Expression of the MAGE gene family in human hepatocellular carcinoma. Cancer 1999; 85: 1234-1240
20. Luo G, Huang S, Xie X, Stockert E, Chen YT, Kubuschok B, Pfreundschuh M. Expression of cancer-testis genes in human hepatocellular carcinomas. Cancer Immun 2002; 2: 11
21. Zhao L, Mou DC, Leng XS, Peng JR, Wang WX, Huang L, Li S, Zhu JY. Expression of cancer-testis antigens in hepatocellular carcinoma. World J Gastroenterol 2004; 10: 2034-2038
22. Henderson JM, Sherman M, Tavill A, Abecassis M, Chejfec G, Gramlich T. AHPBA/AJCC consensus conference on staging of hepatocellular carcinoma: consensus statement. HPB (Oxford) 2003; 5: 243-250
23. Ghafouri-Fard S, Modarressi MH. Cancer-testis antigens: potential targets for cancer immunotherapy. Arch Iran Med 2009; 12: 395-404
24. Ajiro M, Katagiri T, Ueda K, Nakagawa H, Fukukawa C, Lin ML, Park JH, Nishidate T, Daigo Y, Nakamura Y. Involvement of RQCD1 overexpression, a novel cancer-testis antigen, in the Akt pathway in breast cancer cells. Int J Oncol 2009; 35: 673-681
25. Lin ML, Fukukawa C, Park JH, Naito K, Kijima K, Shimo A, Ajiro M, Nishidate T, Nakamura Y, Katagiri T. Involvement of G-patch domain containing 2 overexpression in breast carcinogenesis. Cancer Sci 2009; 100: 1443-1450
26. Bettoni F, Filho FC, Grosso DM, Galante PA, Parmigiani RB, Geraldo MV, Henrique-Silva F, Oba-Shinjo SM, Marie SK, Soares FA, Brentani HP, Simpson AJ, de Souza SJ, Camargo AA. Identification of FAM46D as a novel cancer/testis antigen using EST data and serological analysis. Genomics 2009; 94: 153-160
27. Costa FF, Le Blanc K, Brodin B. Concise review: cancer/testis antigens, stem cells, and cancer. Stem Cells 2007; 25: 707-711
28. Parmigiani RB, Bettoni F, Vibranovski MD, Lopes MH, Martins WK, Cunha IW, Soares FA, Simpson AJ, de Souza SJ, Camargo AA. Characterization of a cancer/testis (CT) antigen gene family capable of eliciting humoral response in cancer patients. Proc Natl Acad Sci USA 2006; 103: 18066-18071
29. Meklat F, Li Z, Wang Z, Zhang Y, Zhang J, Jewell A, Lim SH. Cancer-testis antigens in haematological malignancies. Br J Haematol 2007; 136: 769-776
30. Stevenson BJ, Iseli C, Panji S, Zahn-Zabal M, Hide W, Old LJ, Simpson AJ, Jongeneel CV. Rapid evolution of cancer/testis genes on the X chromosome. BMC Genomics 2007; 8: 129
31. Matsumura M, Niwa Y, Kato N, Komatsu Y, Shiina S, Kawabe T, Kawase T, Toyoshima H, Ihori M, Shiratori Y. Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma. Hepatology 1994; 20: 1418-1425
32. Matsumura M, Niwa Y, Hikiba Y, Okano K, Kato N, Shiina S, Shiratori Y, Omata M. Sensitive assay for detection of hepatocellular carcinoma associated gene transcription (alphafetoprotein mRNA) in blood. Biochem Biophys Res Commun 1995; 207: 813-818
33. Ghossein RA, Rosai J. Polymerase chain reaction in the detection of micrometastases and circulating tumor cells. Cancer 1996; 78: 10-16
34. Komeda T, Fukuda Y, Sando T, Kita R, Furukawa M, Nishida N, Amenomori M, Nakao K. Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood. Cancer 1995; 75: 2214-2219
35. Diel IJ, Kaufmann M, Goerner R, Costa SD, Kaul S, Bastert G. Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. J Clin Oncol 1992; 10: 1534-1539
36. Pelkey TJ, Frierson HF Jr, Bruns DE. Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. Clin Chem 1996; 42: 1369-1381
37. Chou HC, Sheu JC, Huang GT, Wang JT, Chen DS. Albumin messenger RNA is not specific for circulating hepatoma cells. Gastroenterology 1994; 107: 630-631
38. Gion T, Taketomi A, Shimada M, Shirabe K, Hasegawa H, Takenaka K, Sugimachi K. Perioperative change in albumin messenger RNA levels in patients with hepatocellular carcinoma. Hepatology 1998; 28: 1663-1668
39. Wong IH, Lau WY, Leung T, Yeo W, Johnson PJ. Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis. Clin Cancer Res 1999; 5: 4021-4027
40. Witzigmann H, Geissler F, Benedix F, Thiery J, Uhlmann D, Tannapfel A, Wittekind C, Hauss J. Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma. Surgery 2002; 131: 34-43
41. Witzigmann H, Geissler F, Benedix F, Thiery J, Uhlmann D, Tannapfel A, Wittekind C, Hauss J. Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma. Surgery 2002; 131: 34-43
42. Miura N, Maruyama S, Oyama K, Horie Y, Kohno M, Noma E, Sakaguchi S, Nagashima M, Kudo M, Kishimoto Y, Kawasaki H, Hasegawa J, Shiota G. Development of a novel assay to quantify serum human telomerase reverse transcriptase messenger RNA and its significance as a tumor marker for hepatocellular carcinoma. Oncology 2007; 72 Suppl 1: 45-51.
43. Nakamura S, Nouso K, Sakaguchi K, Ito YM, Ohashi Y, Kobayashi Y, Toshikuni N, Tanaka H, Miyake Y, Matsumoto E, Shiratori Y. Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size. Am J Gastroenterol 2006; 101: 2038-2043
44. Giannelli G, Fransvea E, Trerotoli P, Beaugrand M, Marinosci F, Lupo L, Nkontchou G, Dentico P, Antonaci S. Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosis in 961 patients. Clin Chim Acta 2007; 383: 147-152
45. Yoon SK, Lim NK, Ha SA, Park YG, Choi JY, Chung KW, Sun HS, Choi MJ, Chung J, Wands JR, Kim JW. The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma. Cancer Res 2004; 64: 5434-5441